She received her undergraduate degree in Biological Sciences at the University of Palermo, Italy, and in 2010 she earned a PhD in Experimental Oncobiology from the University of Palermo. From 2011 to 2015, she worked as a Post-Doc Researcher at the Italian National Research Council's Institute of Biomedicine and Molecular Immunology (IBIM-CNR) in Palermo, Italy, where she developed a project on the functional role of the signaling pathways that control survival, proliferation and multi-drug resistance in hepatocellular carcinoma (HCC). In 2015, she won a fellowship from the Italian Foundation for Hepatology Research (FIRE). During this period, she studied single nucleotide polymorphisms (SNPs) as possible genetic markers for evaluating the risk of HCC development. Since 2015, she has worked as a Research Fellow, focusing her attention on the study of several aspects of liver cancer biology, in particular identifying new molecular targets and novel therapeutic approaches for HCC. Furthermore, another aspect of interest is molecular mechanisms responsible for the development of non-alcoholic fatty liver disease (NAFLD) with the goal to identify new molecular targets and test therapeutic approaches for steatohepatitis.
